U
University of California, Los Angeles | UCLA Cardiovascular Center
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Pembrolizumab
Vedotin
Edoxaban
Parent organization
This site is a part of University of California, Los Angeles
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
This study is being done to see if a drug called disitamab vedotin, alone or with pembrolizumab, works to treat HER2 expressing urothelial cancer. It...
Enrolling
Urothelial Carcinoma
Drug: pembrolizumab
Drug: disitamab vedotin
This study will enroll participants with urothelial cancer (UC). UC can include cancer of the bladder, kidney, or the tubes that carry pee through th...
Enrolling
Urothelial Carcinoma
Drug: cisplatin
Drug: carboplatin
Trial sponsors
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems